Page last updated: 2024-10-27

fluorouracil and Emphysema, Mediastinal

fluorouracil has been researched along with Emphysema, Mediastinal in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"It is used to treat metastatic colorectal carcinoma."1.62A rare presentation of panitumumab-involved interstitial lung disease: Spontaneous pneumomediastinum. ( Ates, UC; Comert, B; Ergun, B; Gezer, S; Ugur, L; Yakar, N, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yakar, N1
Ergun, B1
Ugur, L1
Ates, UC1
Gezer, S1
Comert, B1

Other Studies

1 other study available for fluorouracil and Emphysema, Mediastinal

ArticleYear
A rare presentation of panitumumab-involved interstitial lung disease: Spontaneous pneumomediastinum.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Leucovor

2021